tryptophan has been researched along with Polycystic Kidney, Autosomal Dominant in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cadnapaphornchai, MA; Chonchol, M; Christians, U; Gitomer, BY; Hopp, K; Jackson, MJ; Klawitter, J; Smith, PH | 1 |
Chonchol, MB; Clambey, ET; Dwivedi, N; Gitomer, BY; Hopp, K; Klawitter, J; Kleczko, EK; Monaghan, MT; Nemenoff, RA; Nguyen, DT | 1 |
2 other study(ies) available for tryptophan and Polycystic Kidney, Autosomal Dominant
Article | Year |
---|---|
Kynurenines in polycystic kidney disease.
Topics: Adult; Child; Disease Progression; Glomerular Filtration Rate; Humans; Inflammation; Kidney; Kynurenine; Polycystic Kidney, Autosomal Dominant; Tryptophan | 2023 |
The tryptophan-metabolizing enzyme indoleamine 2,3-dioxygenase 1 regulates polycystic kidney disease progression.
Topics: Animals; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Mice; Mice, Inbred C57BL; Mice, Knockout; Polycystic Kidney, Autosomal Dominant; Tryptophan; Tryptophan Oxygenase | 2023 |